<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>DNAScribe &#187; Categories</title>
	<atom:link href="http://dnascribe.com/category/categories/feed/" rel="self" type="application/rss+xml" />
	<link>http://dnascribe.com</link>
	<description>Translating Genotyping into Knowledge</description>
	<lastBuildDate>Mon, 22 Sep 2014 00:24:33 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0.1</generator>
		<item>
		<title>Affymetrix: A Changing Technology Landscape – At a Crossing</title>
		<link>http://dnascribe.com/2012/01/affymetrix-a-changing-technology-landscape/</link>
		<comments>http://dnascribe.com/2012/01/affymetrix-a-changing-technology-landscape/#comments</comments>
		<pubDate>Thu, 26 Jan 2012 20:00:39 +0000</pubDate>
		<dc:creator>Elizabeth M. Rogers</dc:creator>
				<category><![CDATA[Companies]]></category>
		<category><![CDATA[Volume 1]]></category>

		<guid isPermaLink="false">http://dnascribe.com/?p=5</guid>
		<description><![CDATA[Affymetrix (AFFX), located in Santa Clara, California, sells patented microarray products. In 2009, Affymetrix experienced revenues of $327.1 million dollars, as opposed to $410.2 Million dollars in 2008. The patented microarray products can be visualized as strands of selected deoxyribonucleic acid (DNA) molecules organized into segments called genes. These are attached to a glass slide...]]></description>
		<wfw:commentRss>http://dnascribe.com/2012/01/affymetrix-a-changing-technology-landscape/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The Adolescent Brain: A brain in flux</title>
		<link>http://dnascribe.com/2010/11/the-adolescent-brain-a-brain-in-flux/</link>
		<comments>http://dnascribe.com/2010/11/the-adolescent-brain-a-brain-in-flux/#comments</comments>
		<pubDate>Tue, 16 Nov 2010 20:00:26 +0000</pubDate>
		<dc:creator>Elizabeth M. Rogers</dc:creator>
				<category><![CDATA[Teens]]></category>
		<category><![CDATA[Volume 1]]></category>

		<guid isPermaLink="false">http://dnascribe.com/?p=19</guid>
		<description><![CDATA[Teenagers are wired to experiment with their environments and find their comfort zone, often amidst chaotic and tumultuous settings. Our species survives as a result of their daring and their insight. 

But what happens when things start to go wrong?  How can a young person turn it around? What can they depend on?  Can they depend on science for answers? Do we make the science accessible to them?]]></description>
		<wfw:commentRss>http://dnascribe.com/2010/11/the-adolescent-brain-a-brain-in-flux/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Plavix: Where do we go next?</title>
		<link>http://dnascribe.com/2010/11/plavix-where-do-we-go-next/</link>
		<comments>http://dnascribe.com/2010/11/plavix-where-do-we-go-next/#comments</comments>
		<pubDate>Tue, 16 Nov 2010 20:00:08 +0000</pubDate>
		<dc:creator>Elizabeth M. Rogers</dc:creator>
				<category><![CDATA[Drugs]]></category>
		<category><![CDATA[Volume 1]]></category>

		<guid isPermaLink="false">http://dnascribe.com/?p=11</guid>
		<description><![CDATA[Plavix is prescribed for more than 25 million people globally and generates in excess of $9 billion dollars in annual sales. Yet, neither the U.S. Food and Drug Administration (FDA), nor the American Heart Association can provide definitive guidance to physicians for determining which patients that need antiplatelet therapy should take Plavix (or clopidogrel, the...]]></description>
		<wfw:commentRss>http://dnascribe.com/2010/11/plavix-where-do-we-go-next/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
